These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31218162)

  • 1. Microglia express GPNMB in the brains of Alzheimer's disease and Nasu-Hakola disease.
    Satoh JI; Kino Y; Yanaizu M; Ishida T; Saito Y
    Intractable Rare Dis Res; 2019 May; 8(2):120-128. PubMed ID: 31218162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease pathology in Nasu-Hakola disease brains.
    Satoh JI; Kino Y; Yanaizu M; Saito Y
    Intractable Rare Dis Res; 2018 Feb; 7(1):32-36. PubMed ID: 29552443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia express ABI3 in the brains of Alzheimer's disease and Nasu-Hakola disease.
    Satoh JI; Kino Y; Yanaizu M; Tosaki Y; Sakai K; Ishida T; Saito Y
    Intractable Rare Dis Res; 2017 Nov; 6(4):262-268. PubMed ID: 29259854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains.
    Satoh J; Tabunoki H; Ishida T; Yagishita S; Jinnai K; Futamura N; Kobayashi M; Toyoshima I; Yoshioka T; Enomoto K; Arai N; Arima K
    Neuropathology; 2011 Aug; 31(4):363-75. PubMed ID: 21118401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of gp91phox and p22phox, catalytic subunits of NADPH oxidase, on microglia in Nasu-Hakola disease brains.
    Satoh JI; Kino Y; Yanaizu M; Tosaki Y; Sakai K; Ishida T; Saito Y
    Intractable Rare Dis Res; 2016 Nov; 5(4):275-279. PubMed ID: 27904823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of GPR17, a regulator of oligodendrocyte differentiation and maturation, in Nasu-Hakola disease brains.
    Satoh JI; Kino Y; Yanaizu M; Tosaki Y; Sakai K; Ishida T; Saito Y
    Intractable Rare Dis Res; 2017 Feb; 6(1):50-54. PubMed ID: 28357182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia express gamma-interferon-inducible lysosomal thiol reductase in the brains of Alzheimer's disease and Nasu-Hakola disease.
    Satoh JI; Kino Y; Yanaizu M; Ishida T; Saito Y
    Intractable Rare Dis Res; 2018 Nov; 7(4):251-257. PubMed ID: 30560017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains.
    Satoh J; Motohashi N; Kino Y; Ishida T; Yagishita S; Jinnai K; Arai N; Nakamagoe K; Tamaoka A; Saito Y; Arima K
    Orphanet J Rare Dis; 2014 May; 9():68. PubMed ID: 24886140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia express TMEM119 in the brains of Nasu-Hakola disease.
    Satoh JI; Kino Y; Yanaizu M; Ishida T; Saito Y
    Intractable Rare Dis Res; 2019 Nov; 8(4):260-265. PubMed ID: 31890453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical characterization of CD33 expression on microglia in Nasu-Hakola disease brains.
    Satoh J; Kino Y; Motohashi N; Ishida T; Yagishita S; Jinnai K; Arai N; Nakamagoe K; Tamaoka A; Saito Y; Arima K
    Neuropathology; 2015 Dec; 35(6):529-37. PubMed ID: 26087043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated Syk expression is enhanced in Nasu-Hakola disease brains.
    Satoh J; Tabunoki H; Ishida T; Yagishita S; Jinnai K; Futamura N; Kobayashi M; Toyoshima I; Yoshioka T; Enomoto K; Arai N; Saito Y; Arima K
    Neuropathology; 2012 Apr; 32(2):149-57. PubMed ID: 21981270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted sequencing approach to identify genetic mutations in Nasu-Hakola disease.
    Satoh JI; Yanaizu M; Tosaki Y; Sakai K; Kino Y
    Intractable Rare Dis Res; 2016 Nov; 5(4):269-274. PubMed ID: 27904822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.
    Sasaki A; Kakita A; Yoshida K; Konno T; Ikeuchi T; Hayashi S; Matsuo H; Shioda K
    Neurogenetics; 2015 Oct; 16(4):265-76. PubMed ID: 26001891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profile of THP-1 monocytes following knockdown of DAP12, a causative gene for Nasu-Hakola disease.
    Satoh J; Shimamura Y; Tabunoki H
    Cell Mol Neurobiol; 2012 Apr; 32(3):337-43. PubMed ID: 22080356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic Expansion in Nasu-Hakola Disease: Immunological Findings in Three Patients and Proposal of a Unifying Pathogenic Hypothesis.
    Errichiello E; Dardiotis E; Mannino F; Paloneva J; Mattina T; Zuffardi O
    Front Immunol; 2019; 10():1685. PubMed ID: 31396216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular Pathogenesis of Nasu-Hakola Disease Brain Lesions].
    Satoh J
    Brain Nerve; 2016 May; 68(5):543-50. PubMed ID: 27156507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TREM2-DAP12 signaling pathway in Nasu-Hakola disease: a molecular genetics perspective.
    Xing J; Titus AR; Humphrey MB
    Res Rep Biochem; 2015; 5():89-100. PubMed ID: 26478868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive astrocytes express Aggregatin (
    Satoh JI; Kino Y; Yanaizu M; Ishida T; Saito Y
    Intractable Rare Dis Res; 2020 Nov; 9(4):217-221. PubMed ID: 33139980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.
    Hüttenrauch M; Ogorek I; Klafki H; Otto M; Stadelmann C; Weggen S; Wiltfang J; Wirths O
    Acta Neuropathol Commun; 2018 Oct; 6(1):108. PubMed ID: 30340518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature.
    Dardiotis E; Siokas V; Pantazi E; Dardioti M; Rikos D; Xiromerisiou G; Markou A; Papadimitriou D; Speletas M; Hadjigeorgiou GM
    Neurobiol Aging; 2017 May; 53():194.e13-194.e22. PubMed ID: 28214109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.